List of Tables
Table 1. Global Vaccines Administered Orally Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccines Administered Orally Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccines Administered Orally Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccines Administered Orally Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vaccines Administered Orally Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccines Administered Orally Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccines Administered Orally Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccines Administered Orally Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccines Administered Orally, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccines Administered Orally, Product Type & Application
Table 12. Global Key Manufacturers of Vaccines Administered Orally, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccines Administered Orally by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Administered Orally as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccines Administered Orally Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccines Administered Orally Sales by Region (2020-2025) & (K Units)
Table 18. Global Vaccines Administered Orally Sales Market Share by Region (2020-2025)
Table 19. Global Vaccines Administered Orally Sales by Region (2026-2031) & (K Units)
Table 20. Global Vaccines Administered Orally Sales Market Share by Region (2026-2031)
Table 21. Global Vaccines Administered Orally Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccines Administered Orally Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccines Administered Orally Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccines Administered Orally Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 27. North America Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 28. North America Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccines Administered Orally Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccines Administered Orally Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vaccines Administered Orally Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vaccines Administered Orally Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccines Administered Orally Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccines Administered Orally Sales (K Units) by Type (2020-2025)
Table 51. Global Vaccines Administered Orally Sales (K Units) by Type (2026-2031)
Table 52. Global Vaccines Administered Orally Sales Market Share by Type (2020-2025)
Table 53. Global Vaccines Administered Orally Sales Market Share by Type (2026-2031)
Table 54. Global Vaccines Administered Orally Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccines Administered Orally Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccines Administered Orally Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccines Administered Orally Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccines Administered Orally Price (US$/Unit) by Type (2020-2025)
Table 59. Global Vaccines Administered Orally Price (US$/Unit) by Type (2026-2031)
Table 60. Global Vaccines Administered Orally Sales (K Units) by Application (2020-2025)
Table 61. Global Vaccines Administered Orally Sales (K Units) by Application (2026-2031)
Table 62. Global Vaccines Administered Orally Sales Market Share by Application (2020-2025)
Table 63. Global Vaccines Administered Orally Sales Market Share by Application (2026-2031)
Table 64. Global Vaccines Administered Orally Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccines Administered Orally Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccines Administered Orally Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccines Administered Orally Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccines Administered Orally Price (US$/Unit) by Application (2020-2025)
Table 69. Global Vaccines Administered Orally Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Vaccines Administered Orally Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Vaccines Administered Orally Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Vaccines Administered Orally Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Company Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lanzhou Institute Vaccines Administered Orally Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Company Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Serum Institute Vaccines Administered Orally Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Company Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Vaccines Administered Orally Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Company Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Vaccines Administered Orally Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Company Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bibcol Vaccines Administered Orally Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Company Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. PaxVax Vaccines Administered Orally Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Company Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Vabiotech Vaccines Administered Orally Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Company Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tiantan Biological Vaccines Administered Orally Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Company Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. EuBiologics Vaccines Administered Orally Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Company Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Panacea Biotec Ltd Vaccines Administered Orally Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Company Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bio-Med Vaccines Administered Orally Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Company Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Vaccines Administered Orally Distributors List
Table 148. Vaccines Administered Orally Customers List
Table 149. Vaccines Administered Orally Market Trends
Table 150. Vaccines Administered Orally Market Drivers
Table 151. Vaccines Administered Orally Market Challenges
Table 152. Vaccines Administered Orally Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccines Administered Orally
Figure 2. Global Vaccines Administered Orally Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccines Administered Orally Market Share by Type: 2024 & 2031
Figure 4. Human Product Picture
Figure 5. Animal Product Picture
Figure 6. Global Vaccines Administered Orally Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vaccines Administered Orally Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Vaccines Administered Orally Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Vaccines Administered Orally Market Size (2020-2031) & (US$ Million)
Figure 12. Global Vaccines Administered Orally Sales (2020-2031) & (K Units)
Figure 13. Global Vaccines Administered Orally Average Price (US$/Unit) & (2020-2031)
Figure 14. Vaccines Administered Orally Report Years Considered
Figure 15. Vaccines Administered Orally Sales Share by Manufacturers in 2024
Figure 16. Global Vaccines Administered Orally Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Vaccines Administered Orally Players: Market Share by Revenue in Vaccines Administered Orally in 2024
Figure 18. Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Vaccines Administered Orally Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 21. North America Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 22. United States Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 25. Europe Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 26. Germany Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Vaccines Administered Orally Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Vaccines Administered Orally Revenue Market Share by Region (2020-2031)
Figure 33. China Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 43. Latin America Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Vaccines Administered Orally by Type (2020-2031)
Figure 53. Global Revenue Market Share of Vaccines Administered Orally by Type (2020-2031)
Figure 54. Global Vaccines Administered Orally Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Vaccines Administered Orally by Application (2020-2031)
Figure 56. Global Revenue Market Share of Vaccines Administered Orally by Application (2020-2031)
Figure 57. Global Vaccines Administered Orally Price (US$/Unit) by Application (2020-2031)
Figure 58. Vaccines Administered Orally Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
